Fellowship ​

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.

Name

Position

Level

Elected

State

Senior Staff Specialist in Haematology and Oncology
Sydney Children’s Hospital
2017
NSW

Professor Glenn Marshall AM is a renowned clinician and researcher in the field of paediatric oncology – having made breakthrough discoveries in both childhood acute lymphoblastic leukaemia and neuroblastoma. As an integral and integrated aspect of Marshall’s research program, he has pursued both the fundamental mechanisms of carcinogenesis and sought to rapidly move these findings into clinical practice.

His frequently world-first research achievements are matched by his profile both nationally and internationally, evidenced by his numerous leadership roles, exceptional level of peer funding and many invitations to speak at leading symposia. Professor Marshall would be an influential addition to the Fellowship.

 

Distinguished Professor Emeritus
Queensland University of Technology
2017
QLD

Distinguished Professor Judith Clements is a recognised world-leading expert on the kallikrein serine proteases and their roles in prostate and ovarian cancers. She was an NHMRC Principal Research Fellow for 16 years from 2000-2016 and is Scientific Director and co-founder of the Australian Prostate Cancer Research Centre-Queensland. She directed the Australian Prostate Cancer BioResource, a key resource nationally, from 2001-2016 and co-leads the Queensland node of the international prostate cancer consortium, PRACTICAL. She is/has been a member of several governance bodies – PCFA (Queensland Chair); International Proteolysis Society, QIMR and QUT Councils – and has served on NHMRC peer review panels since 2000.

Head, Molecular & Cellular Pathology (School of Medicine) and Executive Director Research, Pathology Queensland
University of Queensland and Pathology Queensland, HSQ
2017
QLD

Professor Sunil Lakhani is an internationally recognised clinical and molecular pathologist. He has made significant and sustained contributions to health and medicine, with ongoing research into preinvasive breast cancer and its impact on breast-screening practices; the pathology of BRCA1/2 associated breast cancer; and in developing new therapeutic options for brain metastases, a disease with very poor outcomes. He has developed and implemented clinical practice guidelines including Cancer Australia ‘Management of lobular carcinoma in situ’ and The World Health Organisation Tumour Classification monographs. His work has helped to standardise diagnostic practices throughout the world with resultant impacts on clinical management.

 

 

 

 

Professor and NHMRC Principal Research Fellow
National Drug and Alcohol Research Centre, University of New South Wales
2017
NSW

Louisa Degenhardt’s research on illicit drug use and its health effects has shaped policy at a global level via advice to WHO, UNAIDS, and UNODC. Her data linkage work on opioid dependence has been used internationally to evaluate the benefits risks of addiction treatment. She has published >370 peer reviewed papers, ~190 since 2010; 3 books, 39 book chapters, and 110 reports. Her H-index in Web of Science (WOS) is 48. She has worked on the WHO’s World Mental Health Surveys and co-chairs the Mental Disorders and Illicit Drug Use Expert Group for the 2010 Global Burden of Disease study.

 

 

William Gibson Chair in Otolaryngology
University of Melbourne
2017
VIC

Stephen O’Leary is a surgeon scientist who has dedicated his career to the treatment of hearing loss, especially the prevention of hearing loss during surgical interventions to the inner ear such as cochlear implantation. His experimental finding that steroids protect the ear during cochlear implantation has lead to clinical trials. His team’s development of intraoperative monitoring of hearing directly from the cochlear implant’s electrode is now in global trials and commercial development. Stephen has also explored neural engineering and regenerative medicine approaches to improving cochlear implant performance, developed VR simulators to improve surgical training and contributed to Indigenous ear health.

 

 

 

 

 

 

 

 

AO FAA FASSA FAHMS
Executive Director
Orygen, The National Centre of Excellence in Youth Mental Health
2017
VIC

Professor Patrick McGorry, Australian of the Year 2010, is Executive Director of Orygen, the National Centre of Excellence in Youth Mental Health. He is also Professor of Youth Mental Health at the University of Melbourne and founding member of the National Youth Mental Health Foundation (headspace) board. Professor McGorry and Orygen have put Australia at the forefront of research and innovation in the prevention and treatment of mental illness. With its strong focus on early intervention and educating the community about the early signs of mental illness, Professor McGorry’s research has transformed the lives of tens of thousands of young people the world over.

 

 

 

 

 

 

Chair of Neurology
University of Melbourne
2017
VIC

Professor Kwan is a medical specialist in neurology with particular expertise in epilepsy and molecular precision medicine. His research combines basic and clinical studies, with emphasis on translation of scientific discoveries into clinical practice. He has published >160 peer reviewed papers and book chapters in the world’s top medical journals including, first author, the most highly cited original article in clinical epilepsy in record. His work covers the outcomes, genomics, pharmacogenomics, and mechanisms of drug resistance in epilepsy. To enable widespread implementation of precision medicine he is engineering point-of-care molecular diagnostic devices for application in neurological diseases and other conditions.

 

 

 

Professor, Biomedical Engineering; Sir John Eccles Chair of Medicine and Director of Clinical Neurosciences, St. Vincent’s Hospital
University of Melbourne
2017
VIC

Mark Cook has demonstrated a sustained contribution and leadership in medical research over a 25-year period. He is highly regarded internationally for his research excellence in neurology, and in the field of epilepsy in particular. He has made significant contributions to health science through his research, clinical, administrative, and educational roles at both St. Vincents Hospital and University of Melbourne. Cook actively engages in community awareness and advocacy regarding epilepsy, as Chairman of the Epilepsy Foundation of Victoria, a major community not-for-profit organisation, and participates regularly in public discussion of medical research via the media and public forums.

 

Clinical Director, Division of Medicine and Cancer
Westmead Hospital
2017
NSW

Honoured “for eminent service to medicine, particularly in the areas of clinical and biomedical research, to the development of ethical policy and practices for organ donation, acquisition and transplantation, and to renal medicine organisations and publications, Jeremy Chapman AC has played significant roles in development of kidney, pancreas and unrelated Bone Marrow Transplantation in Australia. He has been responsible for global development of ethical transplantation through The Transplantation Society, the World Marrow Donor Association and through advisory roles to the World Health Organisation. He is identified as one of the most influential global leaders in the field of clinical transplantation.

Professor of Pharmacology and NHMRC Senior Principal Research Fellow
Monash Institute of Pharmaceutical Sciences
2017
VIC

“Discovery and dissemination of the concept of allosteric sites on receptor proteins as a novel avenue for drug discovery”.
Professor Christopoulos has demonstrated how this approach can be used to identify, validate, quantify, and facilitate preclinical translation of small molecules with an allosteric mode of action for all classes of G protein-coupled receptor (GPCR), the largest group of drug targets. His research is highly cited (top 1% in discipline), has made it into the textbooks, been acknowledged via the highest honours from the Australian, USA, UK and world (IUPHAR) Pharmacological Societies, and transformed the way GPCR drug modulators are discovered.

About Fellowship with AAHMS

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

To ensure the Academy has a representative and diverse membership, Fellows nominating two new candidates are asked to include only a maximum of one man, and Fellows nominating four new candidates are asked to include only a maximum of two men.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2023
Newly elected Fellows of 2023 are inducted at the Annual Meeting.

18 September 2023- 30 November 2023
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2023
Nominations allocated to Selection Committees.

January – April 2024
Referees’ reports sought.

Early May 2024
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2024
Council meets to finalise recommendations.

Late July 2024
Full Fellowship invited to comment on recommended new fellows.

August 2024
Election results are shared with proposers and candidates (under embargo).

October 2024
Newly elected Fellows of 2024 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.